Alnylam Pharmaceuticals I...
240.92
-17.35 (-6.72%)
At close: Jan 14, 2025, 3:59 PM
246.00
2.11%
Pre-market Jan 15, 2025, 08:51 AM EST

Alnylam Pharmaceuticals Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018
GIVLAARI Revenue 71.04M 62.13M 58.06M 165.10M 54.15M 305.70M 276.33M 261.68M 232.27M 213.51M 186.87M 198.51M 167.04M 160.81M 135.77M 112.84M 99.21M 11.00M 5.27M 46.07M 38.23M 26.29M 12.07M 460.00K
GIVLAARI Revenue Growth +14.35% +7.01% -64.84% +204.91% -82.29% +10.63% +5.60% +12.66% +8.78% +14.26% -5.86% +18.84% +3.88% +18.44% +20.32% +13.75% +802.04% +108.53% -88.55% +20.49% +45.41% +117.73% +2525.00% n/a
ONPATTRO Revenue 50.29M 77.24M 69.22M 346.29M 81.59M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 66.53M 66.66M n/a n/a n/a n/a n/a
ONPATTRO Revenue Growth -34.89% +11.60% -80.01% +324.43% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -0.19% n/a n/a n/a n/a n/a n/a
Product Revenue 420.15M 410.09M 365.16M n/a 313.15M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 71.94M n/a n/a n/a n/a n/a
Product Revenue Growth +2.45% +12.30% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Europe Revenue 210.92M 37.91M 38.95M 333.00K 116.45M
Europe Revenue Growth +456.29% -2.65% +11596.40% -99.71% n/a
Non-Us Or Europe Revenue 75.77M 4.17M 1.76M 46.75M n/a
Non-Us Or Europe Revenue Growth +1717.49% +136.74% -96.23% n/a n/a
United States Revenue 411.17M 27.70M 18.88M 151.57M n/a
United States Revenue Growth +1384.47% +46.74% -87.55% n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 220.99M 248.40M 210.80M 198.12M 199.18M 214.69M 183.66M 210.34M 235.86M 169.98M 154.47M 186.38M 142.07M 145.32M 146.86M 166.29M 167.47M 127.90M 126.76M 156.28M 120.35M 112.77M 89.61M 108.69M 116.55M 84.68M 72.45M 67.45M 47.64M 45.78M 38.49M 27.88M 22.39M 17.99M 21.10M 17.23M 16.04M 14.62M 12.72M
Selling, General, and Administrative Revenue Growth -11.03% +17.84% +6.40% -0.53% -7.23% +16.90% -12.69% -10.82% +38.75% +10.04% -17.12% +31.19% -2.24% -1.05% -11.69% -0.71% +30.94% +0.90% -18.89% +29.85% +6.72% +25.85% -17.55% -6.74% +37.63% +16.88% +7.40% +41.58% +4.07% +18.95% +38.07% +24.50% +24.48% -14.75% +22.48% +7.43% +9.67% +14.92% n/a
Research and Development Revenue 270.93M 294.14M 261.00M 272.14M 253.18M 248.53M 230.57M 262.04M 245.37M 205.71M 169.89M 229.05M 194.57M 182.63M 185.90M 168.47M 161.78M 155.00M 169.57M 201.30M 160.80M 163.89M 129.13M 131.04M 139.94M 137.58M 96.86M 117.77M 95.25M 90.63M 86.98M 105.01M 97.94M 83.17M 96.27M 82.83M 68.62M 67.01M 58.03M
Research and Development Revenue Growth -7.89% +12.70% -4.10% +7.49% +1.87% +7.79% -12.01% +6.79% +19.28% +21.08% -25.83% +17.72% +6.54% -1.76% +10.35% +4.13% +4.38% -8.60% -15.76% +25.19% -1.89% +26.92% -1.46% -6.37% +1.72% +42.05% -17.76% +23.64% +5.10% +4.19% -17.17% +7.22% +17.75% -13.61% +16.22% +20.72% +2.40% +15.46% n/a

Create Price Alert on ALNY

Your price alert will notify you when the stock price is above 240.92.

Add to Watchlist